The Child Mind Institute Names Dr. Vera Feuer as Chief Clinical Officer

Feuer brings more than two decades of clinical leadership to inaugural role 

New York, NY – The Child Mind Institute, an independent nonprofit dedicated to transforming the lives of children affected by mental health disorders, today announced Vera Feuer, MD, as the organization’s first-ever Chief Clinical Officer. A seasoned specialist in pediatric and adolescent mental health, Dr. Feuer will oversee clinical strategy, including patient care in the New York City and San Francisco Bay Area offices, and help drive innovation across treatment and research. 

Dr. Feuer most recently served as Vice President of Child and Adolescent Psychiatry at Northwell Health and is a professor of psychiatry, pediatrics, and emergency medicine at the Zucker School of Medicine at Hofstra/Northwell Health. A board-certified psychiatrist, she brings more than 20 years of clinical expertise and leadership in pediatric and adolescent mental health and crisis care to the Child Mind Institute. She has helped pioneer innovative standards of care in pediatric crisis behavioral health care and suicide prevention, and she has led the development of programs for the pediatric medical community and school district partnerships to expand mental health care access for students.  

“I am thrilled to join the Child Mind Institute and beyond excited to bring my extensive experience of working with youth and families, creating access to care and innovative program development, and to work with this remarkable team,” Dr. Feuer says. “Together we will deepen access to high-quality, evidence-based care and develop programs that meet the needs of kids where they are.” 

Dr. Feuer will provide strategic oversight to a multidisciplinary team of more than 70 clinicians who deliver over 70,000 patient appointments annually, ensuring continued excellence in delivering care, developing school-based programs, and establishing community partnerships while expanding access to high-quality mental health services. As a member of the Child Mind Institute’s executive leadership, Dr. Feuer will be instrumental in shaping the organization’s clinical vision, providing medical expertise to improve outcomes for children and families and guiding the integration of research through data-driven approaches that advance care and innovation. 

“At a time when youth mental health needs are more urgent than ever, Dr. Feuer’s exceptional leadership brings crucial guidance to meet this moment,” says Harold S. Koplewicz, MD, founding president and medical director of the Child Mind Institute. “Our mission has always been to transform how families access and experience mental health care. With Dr. Feuer at the helm as our Chief Clinical Officer, we remain steadfast in our commitment to strengthening our clinical foundation, shaping the future of mental health and helping families nationwide.” 

To learn more, visit childmind.org, and read Dr. Feuer’s full biography


About the Child Mind Institute 

The Child Mind Institute is dedicated to transforming the lives of children and families struggling with mental health and learning disorders by giving them the help they need. We’ve become the leading independent nonprofit in children’s mental health by providing gold-standard, evidence-based care, delivering educational resources to millions of families each year, training educators in underserved communities, and developing tomorrow’s breakthrough treatments. 

Visit Child Mind Institute on social media: InstagramFacebookXLinkedIn 

For press questions, contact our press team at childmindinstitute@ssmandl.com or our media officer at mediaoffice@childmind.org

The post The Child Mind Institute Names Dr. Vera Feuer as Chief Clinical Officer appeared first on Child Mind Institute.

Depressive Symptoms Are Associated with Altered Development of Amygdala-Ventrolateral Prefrontal Connectivity During Implicit Emotion Regulation Across Adolescence

Adolescence is characterized by extensive development in neural circuits that support emotion processing and regulation, and by increased risk for depression. While altered frontolimbic functioning during emotion processing has been implicated in youth with depression relative to healthy controls, the directions of the associations have been inconsistent.

<![CDATA[Round on the latest news in psychiatry from the last week.]]>

STAT+: Biotech raises $42 million to run Huntington’s disease trial

Gene therapy startup Latus Bio has raised another $42 million to start its first clinical trials, where it will try to sidestep issues that have set back a more advanced competitor. 

Latus is moving two treatments through clinical trials this year. The first is for a form of Batten disease called CLN2 disease, a fatal genetic condition that causes seizures, vision loss, and cognitive problems. The company anticipates having initial clinical data by the end of the year. 

Now, Latus — founded by Beverly Davidson, chief scientific strategy officer at the Children’s Hospital of Philadelphia — is turning its attention to a second drug candidate, a gene therapy for Huntington’s disease.

Continue to STAT+ to read the full story…

Immigration changes are driving foreign researchers to leave the U.S. — or not come to begin with 

The budding scientist had left India for the U.S. for her Ph.D., because as she saw it, no other country offered the same opportunities for researchers. Set to finish her doctorate this summer, she also had a postdoctoral fellowship lined up in America.

Now those plans have changed. New and intrusive burdens for renewing a component of her visa — which required her to make public her social media profiles for U.S. review while she was back in India — caused her to be away from the lab for two months during the crunch time of wrapping up her degree. 

Read the rest…